Wednesday 31 July 2013

Dysfunction Of The Autonomic Nervous System May Be A Marker Of Later Development Of Certain Types Of Kidney Disease

Dysfunction Of The Autonomic Nervous System May Be A Marker Of Later Development Of Certain Types Of Kidney Disease.
A person's empathy spent may proposition discernment into their tomorrow kidney health, a new study suggests canada. A high-priced resting heart rate and low beat-to-beat quintessence rate variability were noted in study patients with an increased endanger for kidney disease, according to a report released online July 8 in go on of publication in an upcoming print issue of the Journal of the American Society of Nephrology.

The find suggests that dysfunction of the autonomic highly-strung system - which regulates involuntary body functions such as fundamentals rate, blood pressure, temperature and stress effect - may be a marker for late development of certain types of kidney disease, explained Dr Daniel Brotman of Johns Hopkins University School of Medicine and colleagues, in a information publicity release from the American Society of Nephrology. Previous studies have suggested a associate between autonomic troubled system dysfunction (dysautonomia) and chronic kidney condition and its progression.

Monday 22 July 2013

Dapagliflozin Is A New Drug For The Treatment Of Type Two Diabetes

Dapagliflozin Is A New Drug For The Treatment Of Type Two Diabetes.
A unexplored drug, the essential in its class, gives added blood sugar device to living souls with type 2 diabetes who are already fascinating the glucose-lowering medication metformin. The new agent, dapagliflozin, which also helped patients elude weight, is novel in that it does not position directly on the body's insulin mechanisms, according to a study appearing in the June 26 son of The Lancet and slated for presentation at the annual engagement of the American Diabetes Association (ADA) in Orlando wheretobuyrx. "It will perhaps be used as an add-on therapy," said bookwork lead author Clifford Bailey, a chemical pathologist and professor of clinical information at Aston University in Birmingham, UK "If you don't undoubtedly get to target with the first therapy tried , this closer would offer you an opportunity hopefully to maintain improved control".

Bailey, who could not augur if or when the drug might get final approval from numb regulatory authorities, also pointed out that dapagliflozin is flexible, meaning it can be employed with various other treatments and at more or less any stage in the disease. "It's a good add-on," agreed Dr Stanley Mirsky, associated clinical professor of metabolic diseases at Mount Sinai Medical Center in New York City. "Is it a awe drug? No. It may disport a shallow role".

The study was funded by Bristol-Myers Squibb and AstraZeneca, which are developing dapagliflozin together. Dapagliflozin factory by thought-provoking the kidneys to eliminate more glucose from the body via urine. In this consider of 534 adult patients with type 2 diabetes who were already prepossessing metformin, the highest dose of dapagliflozin (10 milligrams daily) was associated with a 0,84 percent subsidence in HbA1c levels.

HbA1c is a metre of blood sugar control over time. Participants engaging 5 mg of the drug saw a 0,70 percent dwindling in HbA1c levels, while those taking 2.5 mg had a 0,67 percent decrease. In the placebo group, the subside in HbA1c was 0,3 percent, the scrutiny found.

Tuesday 16 July 2013

Non-Invasive Diagnosis Of Traumatic Dementia At An Early Stage

Non-Invasive Diagnosis Of Traumatic Dementia At An Early Stage.
A "virtual biopsy" may facilitate analyse a degenerative wit disorder that can occur in gifted athletes and others who suffer repeated blows to the head, says a original study. Symptoms of chronic traumatic encephalopathy (CTE) can allow for memory problems, impulsive and erratic behavior, downturn and, eventually, dementia canada. The condition, which is noticeable by an accumulation of abnormal proteins in the brain, can only be diagnosed by an autopsy.

But a specialized imaging ability called magnetic resonance spectroscopy (MRS) may sell a noninvasive way to diagnose CTE at an first stage so that treatment can begin before further brain damage occurs, say US researchers. MRS - occasionally referred to as "virtual biopsy" - uses compelling magnetic field and present waves to gather information about chemical compounds in the body. The researchers second-hand MRS to examine five retired seasoned male football players, wrestlers and boxers, ages 32 to 55, with suspected CTE and compared them to a lead team of five age-matched men.

Thursday 4 July 2013

Reducing Mortality From Coronary Heart Disease

Reducing Mortality From Coronary Heart Disease.
Improved treatment, coupled with more useful curb measures, may be having a convincing impact on the death rate from coronary sensitivity disease. Death rate data from the United States and Canada both say a drop in cardiovascular deaths buying. According to the American Heart Association, the annual eradication rate from coronary centre disease from 1996 to 2006 declined 36,4 percent and the tangible death rate dropped 21,9 percent.

In Canada, according to a lessons in the May 12 issue of the Journal of the American Medical Association, the annihilation rate from coronary heart disease in the responsibility of Ontario fell by 35 percent from 1994 to 2005. "The overall goodness news is that coronary heart mortality continued to go down in defiance of people growing older," said study novelist Dr Harindra C Wijeysundera, a cardiologist at the Sunnybrook Health Sciences Centre Schulich Heart Centre in Toronto. "Risk determinant changes appear to against a very important role," he said, "accounting for just under half the increase despite increasing availability of better treatments". And, he added, "the strange therapies are being well-used".

But there is a cloud on the view that darkens the generally cheery report, Wijeysundera noted. "Diabetes and avoirdupois are on the increase," he said. "It doesn't entertain much of a negative trend in diabetes and obesity to drop the good trends". A 1 percent increase in diabetes correlates to a 6 percent raise in mortality, he said.